tiprankstipranks
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H (HK:1858)
:1858
Hong Kong Market
Want to see HK:1858 full AI Analyst Report?

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H (1858) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H has a market cap or net worth of HK$7.71B. The enterprise value is HK$5.99B.
Market CapHK$7.71B
Enterprise ValueHK$5.99B

Share Statistics

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H has 95,140,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding95,140,500
Owned by Insiders
Owned by Institutions

Financial Efficiency

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 7.58%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)7.58%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee816.95K
Profits Per Employee214.62K
Employee Count1,237
Asset Turnover0.28
Inventory Turnover0.69

Valuation Ratios

The current PE Ratio of Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H is 19.3. Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s PEG ratio is 0.18.
PE Ratio19.3
PS Ratio5.06
PB Ratio1.71
Price to Fair Value1.71
Price to FCF14.53
Price to Operating Cash Flow18.32
PEG Ratio0.18

Income Statement

In the last 12 months, Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H had revenue of 1.01B and earned 265.08M in profits. Earnings per share was 0.69.
Revenue1.01B
Gross Profit639.61M
Operating Income259.14M
Pretax Income293.42M
Net Income265.08M
EBITDA299.86M
Earnings Per Share (EPS)0.69

Cash Flow

In the last 12 months, operating cash flow was 412.82M and capital expenditures -59.53M, giving a free cash flow of 353.29M billion.
Operating Cash Flow412.82M
Free Cash Flow353.29M
Free Cash Flow per Share3.71

Dividends & Yields

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H pays an annual dividend of HK$0.23, resulting in a dividend yield of 1.88%
Dividend Per ShareHK$0.23
Dividend Yield1.88%
Payout Ratio31.64%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.19
52-Week Price Change43.82%
50-Day Moving Average13.20
200-Day Moving Average15.08
Relative Strength Index (RSI)53.53
Average Volume (3m)1.20M

Important Dates

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H upcoming earnings date is Apr 30, 2026, TBA (Confirmed).
Last Earnings DateMar 30, 2026
Next Earnings DateApr 30, 2026
Ex-Dividend Date

Financial Position

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H as a current ratio of 5.20, with Debt / Equity ratio of 0.13%
Current Ratio5.20
Quick Ratio4.28
Debt to Market Cap<0.01
Net Debt to EBITDA-4.69
Interest Coverage Ratio1.29K

Taxes

In the past 12 months, Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H has paid 28.33M in taxes.
Income Tax28.33M
Effective Tax Rate0.10

Enterprise Valuation

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H EV to EBITDA ratio is 12.37, with an EV/FCF ratio of 10.54.
EV to Sales3.67
EV to EBITDA12.37
EV to Free Cash Flow10.54
EV to Operating Cash Flow9.06

Balance Sheet

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H has HK$2.22B in cash and marketable securities with HK$3.78M in debt, giving a net cash position of HK$2.22B billion.
Cash & Marketable SecuritiesHK$2.22B
Total DebtHK$3.78M
Net CashHK$2.22B
Net Cash Per ShareHK$23.31
Tangible Book Value Per ShareHK$7.70

Margins

Gross margin is 65.54%, with operating margin of 25.64%, and net profit margin of 26.23%.
Gross Margin65.54%
Operating Margin25.64%
Pretax Margin29.04%
Net Profit Margin26.23%
EBITDA Margin29.67%
EBIT Margin25.64%

Analyst Forecast

The average price target for Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast29.94%
EPS Growth Forecast119.16%

Scores

Smart Score5
AI Score